Buy One Get One free -Llimited Time Offer X
Geftiglan is a prescription medicine that is available as a Tablet. Primarily, it is used for the treatment of Non-Small Cell Lung Cancer. The alternative uses of Geftiglan have also been explained below.
The optimal dosage of Geftiglan is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
The side effects typically associated with Geftiglan include Weakness, Dry Skin, Dark colored (brown) urine. Besides the aforementioned side effects, there are other adverse effects of Geftiglan as well, which are listed below. Normally, these side effects of Geftiglan are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Geftiglan has a Severe effect for pregnant women and Severe effect on lactating mothers. In addition, Geftiglan's effects on the liver, heart and kidney are discussed below in the Geftiglan related warnings section.
Geftiglan is not recommended if you suffer from certain medical conditions as it can have adverse effects. Liver Disease, Gastritis are examples of such conditions. Other conditions have been mentioned below in the Geftiglan contraindications section.
Additionally, Geftiglan may also adversely react with other medicines. See below for a complete list.
You should also be aware that Geftiglan is not safe while driving, and is not addiction.
Geftiglan is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Based on research, the following side effects have been observed when Geftiglan is used -
Severe
Moderate
Mild
Common
Is the use of Geftiglan safe for pregnant women?
Geftiglan can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Geftiglan safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Geftiglan. So it is adviced to consult the doctor before using it.
What is the effect of Geftiglan on the Kidneys?
Very few cases of side effects of Geftiglan on kidney have been reported.
What is the effect of Geftiglan on the Liver?
Geftiglan is rarely harmful for the liver.
What is the effect of Geftiglan on the Heart?
Geftiglan is not harmful for the heart.
Geftiglan should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Geftiglan unless your doctor advises you to do so -
Is this Geftiglan habit forming or addictive?
No, you will not get addicted to Geftiglan.
Is it safe to drive or operate heavy machinery when consuming?
After taking Geftiglan you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, but consume Geftiglan only on doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Geftiglan for mental disorders.
Interaction between Food and Geftiglan
Taking Geftiglan with food does not cause any problems.
Interaction between Alcohol and Geftiglan
Information about the interaction of Geftiglan and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Iressa (gefitinib tablets)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 870
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 610-612